vs
雅培（ABT）与Aveanna Healthcare Holdings, Inc.（AVAH）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是Aveanna Healthcare Holdings, Inc.的18.4倍（$11.5B vs $621.9M）。雅培净利率更高（15.5% vs 2.3%，领先13.2%）。Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 4.4%）。过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs 7.2%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
ABT vs AVAH — 直观对比
营收规模更大
ABT
是对方的18.4倍
$621.9M
营收增速更快
AVAH
高出17.8%
4.4%
净利率更高
ABT
高出13.2%
2.3%
两年增速更快
AVAH
近两年复合增速
7.2%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $621.9M |
| 净利润 | $1.8B | $14.1M |
| 毛利率 | 57.0% | 32.6% |
| 营业利润率 | 19.6% | 8.6% |
| 净利率 | 15.5% | 2.3% |
| 营收同比 | 4.4% | 22.2% |
| 净利润同比 | -80.8% | 132.8% |
| 每股收益（稀释后） | $1.01 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTAVAH
| Q4 25 | $11.5B | — | ||
| Q3 25 | $11.4B | $621.9M | ||
| Q2 25 | $11.1B | $589.6M | ||
| Q1 25 | $10.4B | $559.2M | ||
| Q4 24 | $11.0B | $519.9M | ||
| Q3 24 | $10.6B | $509.0M | ||
| Q2 24 | $10.4B | $505.0M | ||
| Q1 24 | $10.0B | $490.7M |
净利润ABTAVAH
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.6B | $14.1M | ||
| Q2 25 | $1.8B | $27.0M | ||
| Q1 25 | $1.3B | $5.2M | ||
| Q4 24 | $9.2B | $29.2M | ||
| Q3 24 | $1.6B | $-42.8M | ||
| Q2 24 | $1.3B | $13.9M | ||
| Q1 24 | $1.2B | $-11.2M |
毛利率ABTAVAH
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | 32.6% | ||
| Q2 25 | 56.4% | 35.8% | ||
| Q1 25 | 56.9% | 32.8% | ||
| Q4 24 | 55.0% | 33.0% | ||
| Q3 24 | 55.8% | 31.4% | ||
| Q2 24 | 55.6% | 31.3% | ||
| Q1 24 | 55.2% | 29.7% |
营业利润率ABTAVAH
| Q4 25 | 19.6% | — | ||
| Q3 25 | 18.1% | 8.6% | ||
| Q2 25 | 18.4% | 13.6% | ||
| Q1 25 | 16.3% | 9.3% | ||
| Q4 24 | 17.4% | 8.8% | ||
| Q3 24 | 17.5% | 6.7% | ||
| Q2 24 | 16.1% | 7.4% | ||
| Q1 24 | 13.9% | 4.7% |
净利率ABTAVAH
| Q4 25 | 15.5% | — | ||
| Q3 25 | 14.5% | 2.3% | ||
| Q2 25 | 16.0% | 4.6% | ||
| Q1 25 | 12.8% | 0.9% | ||
| Q4 24 | 84.1% | 5.6% | ||
| Q3 24 | 15.5% | -8.4% | ||
| Q2 24 | 12.5% | 2.8% | ||
| Q1 24 | 12.3% | -2.3% |
每股收益（稀释后）ABTAVAH
| Q4 25 | $1.01 | — | ||
| Q3 25 | $0.94 | $0.06 | ||
| Q2 25 | $1.01 | $0.13 | ||
| Q1 25 | $0.76 | $0.03 | ||
| Q4 24 | $5.26 | $0.15 | ||
| Q3 24 | $0.94 | $-0.22 | ||
| Q2 24 | $0.74 | $0.07 | ||
| Q1 24 | $0.70 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $145.9M |
| 总债务越低越好 | $12.9B | $1.3B |
| 股东权益账面价值 | $52.1B | $9.2M |
| 总资产 | $86.7B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.25× | 141.83× |
8季度趋势，按日历期对齐
现金及短期投资ABTAVAH
| Q4 25 | $8.9B | — | ||
| Q3 25 | $7.7B | $145.9M | ||
| Q2 25 | $7.3B | $100.7M | ||
| Q1 25 | $6.8B | $71.5M | ||
| Q4 24 | $8.0B | $84.3M | ||
| Q3 24 | $7.8B | $78.5M | ||
| Q2 24 | $7.2B | $47.7M | ||
| Q1 24 | $6.7B | $42.6M |
总债务ABTAVAH
| Q4 25 | $12.9B | — | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $14.1B | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
股东权益ABTAVAH
| Q4 25 | $52.1B | — | ||
| Q3 25 | $51.0B | $9.2M | ||
| Q2 25 | $50.6B | $-12.0M | ||
| Q1 25 | $48.8B | $-100.1M | ||
| Q4 24 | $47.7B | $-123.6M | ||
| Q3 24 | $39.8B | $-156.4M | ||
| Q2 24 | $39.3B | $-119.0M | ||
| Q1 24 | $38.8B | $-136.3M |
总资产ABTAVAH
| Q4 25 | $86.7B | — | ||
| Q3 25 | $84.2B | $1.8B | ||
| Q2 25 | $84.0B | $1.8B | ||
| Q1 25 | $81.4B | $1.7B | ||
| Q4 24 | $81.4B | $1.7B | ||
| Q3 24 | $74.4B | $1.6B | ||
| Q2 24 | $73.0B | $1.7B | ||
| Q1 24 | $72.5B | $1.6B |
负债/权益比ABTAVAH
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | 141.83× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $33.2M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | — |
| 自由现金流率自由现金流/营收 | 22.9% | — |
| 资本支出强度资本支出/营收 | 6.0% | — |
| 现金转化率经营现金流/净利润 | 1.87× | 2.36× |
| 过去12个月自由现金流最近4个季度 | $7.4B | — |
8季度趋势，按日历期对齐
经营现金流ABTAVAH
| Q4 25 | $3.3B | — | ||
| Q3 25 | $2.8B | $33.2M | ||
| Q2 25 | $2.0B | $51.6M | ||
| Q1 25 | $1.4B | $-8.6M | ||
| Q4 24 | $2.9B | $13.4M | ||
| Q3 24 | $2.7B | $29.4M | ||
| Q2 24 | $2.0B | $1.8M | ||
| Q1 24 | $1.0B | $-12.0M |
自由现金流ABTAVAH
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $933.0M | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $627.0M | — |
自由现金流率ABTAVAH
| Q4 25 | 22.9% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 20.2% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 6.3% | — |
资本支出强度ABTAVAH
| Q4 25 | 6.0% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.0% | — |
现金转化率ABTAVAH
| Q4 25 | 1.87× | — | ||
| Q3 25 | 1.70× | 2.36× | ||
| Q2 25 | 1.15× | 1.91× | ||
| Q1 25 | 1.07× | -1.66× | ||
| Q4 24 | 0.31× | 0.46× | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.51× | 0.13× | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
